CJC-1295 (No DAC) 5mg + Ipamorelin 5mg Research Peptide Combo

THRYV CJC-1295 (No DAC) 5mg + Ipamorelin 5mg is a dual research peptide combination supplied for laboratory and pre-clinical research use only. This combo includes two individually measured peptides provided together to support research models examining growth hormone–related signaling, receptor interaction, and peptide synergy in controlled environments.

CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog without a Drug Affinity Complex, allowing researchers to evaluate short-duration signaling dynamics, receptor binding activity, and temporal peptide behavior without albumin binding.

Ipamorelin (IPA) is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS) and has been examined in pre-clinical research models related to ghrelin receptor signaling and growth hormone pathway activation.

Each component in this combo is COA verified and independently tested to confirm purity and identity, supporting consistency and reproducibility across research applications.

This product is packaged as a convenient research peptide combo, suitable for parallel or comparative laboratory studies.

For laboratory research use only. Not for human or veterinary consumption.
This product is not FDA-approved and is supplied strictly for research purposes.